Founded in 1849, Pfizer Inc. is one of the world’s largest research based pharmaceutical corporations, developing and producing medicines and vaccines for medical disciplines including immunology, oncology, cardiology, endocrinology and neurology. Within its operating divisions including primary and specialty care, oncology, emerging markets, established products, consumer healthcare, nutrition and animal health, Pfizer prioritizes research. The two groups Pharma-Therapeutics and Bio-Therapeutics Research and Development Groups focus on small and large molecules and related modalities. In 2008 Pfizer established the Regenerative Medicine Research Unit, focused upon understanding and utilizing the biology of stem cells in order to treat today’s degenerative diseases.
Pfizer is actively involved with international partners including the Gates Foundation and GAVI the Vaccine Alliance, projects including providing contraceptive injections and anti-pneumococcal vaccines in the developing world as well as treatment for HIV/AIDS related infections via the provision of Diflucan to NGOs in developing countries. Since 2000, Pfizer has provided over US$1.2 billion of this aid to 63 countries across Africa, Asia, the Caribbean and Latin America.
